No black box warning on record for Empliciti

As of the latest FDA labeling reviewed, Empliciti (ELOTUZUMAB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Empliciti medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Infusion reactions: Premedication is required. Interrupt EMPLICITI for Grade 2 or higher and permanently discontinue for severe infusion reaction. ( 2.3 , 2.4 , 5.1) • Infections: Monitor for fever and other signs of infection and treat promptly. (5.2) • Second Primary Malignancies (SPM): Higher incidences of SPM were observed in a controlled clinical trial of patients

No black box warning on record for Empliciti

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Infusion reactions: Premedication is required. Interrupt EMPLICITI for Grade 2 or higher and permanently discontinue for severe infusion reaction. ( 2.3 , 2.4 , 5.1) • Infections: Monitor for fever and other signs of infection and treat promptly. (5.2) • Second Primary Malignancies (SPM): Higher incidences of SPM were observed in a controlled clinical trial of patients

Empliciti Black Box Warning

No black box warning on record for Empliciti

Other warnings & precautions

Empliciti Black Box Warning

No black box warning on record for Empliciti

Other warnings & precautions